Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

FKBP5 isoforms shape immune pathways related to tumor tolerance.

Cell death discovery·2026
Same author

IUPAC-induced computational approaches for identifying boosters of small biomolecule functionality: A case study of human tyrosyl-DNA phosphodiesterase 1 (TDP1) inhibitors.

Computers in biology and medicine·2026
Same author

On the Emergent "Quantum" Theory in Complex Adaptive Systems.

ArXiv·2023
Same author

Classification of Speaking and Singing Voices Using Bioimpedance Measurements and Deep Learning.

Journal of voice : official journal of the Voice Foundation·2023
Same author

A Point-of-Care Device for Fully Automated, Fast and Sensitive Protein Quantification via qPCR.

Biosensors·2022
Same author

Eye Accommodation Sensing for Adaptive Focus Adjustment.

Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference·2021

Related Experiment Video

Updated: Jul 8, 2026

Assessment of Spontaneous Alternation, Novel Object Recognition and Limb Clasping in Transgenic Mouse Models of Amyloid-β and Tau Neuropathology
10:02

Assessment of Spontaneous Alternation, Novel Object Recognition and Limb Clasping in Transgenic Mouse Models of Amyloid-β and Tau Neuropathology

Published on: May 28, 2017

27.1K

Targeting neurodegeneration: three machine learning methods for G9a inhibitors discovery using PubChem and

Mariya L Ivanova1, Nicola Russo2, Konstantin Nikolic2

  • 1School of Computing and Engineering, University of West London, London, UK. mariya.ivanova@uwl.ac.uk.

Journal of Computer-Aided Molecular Design
|August 6, 2025
PubMed
Summary

Three machine learning models were developed to predict G9a inhibitor efficacy and activity, offering time and cost-effective tools for neuroscience research. These models utilize PubChem data and scikit-learn algorithms for efficient drug discovery support.

Keywords:
CID_SID ML modelG9a inhibitor efficacyIUPAC based ML model

More Related Videos

Studying Pre-formed Fibril Induced α-Synuclein Accumulation in Primary Embryonic Mouse Midbrain Dopamine Neurons
10:03

Studying Pre-formed Fibril Induced α-Synuclein Accumulation in Primary Embryonic Mouse Midbrain Dopamine Neurons

Published on: August 16, 2020

10.7K
Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons
08:04

Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons

Published on: June 6, 2025

500

Related Experiment Videos

Last Updated: Jul 8, 2026

Assessment of Spontaneous Alternation, Novel Object Recognition and Limb Clasping in Transgenic Mouse Models of Amyloid-β and Tau Neuropathology
10:02

Assessment of Spontaneous Alternation, Novel Object Recognition and Limb Clasping in Transgenic Mouse Models of Amyloid-β and Tau Neuropathology

Published on: May 28, 2017

27.1K
Studying Pre-formed Fibril Induced α-Synuclein Accumulation in Primary Embryonic Mouse Midbrain Dopamine Neurons
10:03

Studying Pre-formed Fibril Induced α-Synuclein Accumulation in Primary Embryonic Mouse Midbrain Dopamine Neurons

Published on: August 16, 2020

10.7K
Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons
08:04

Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons

Published on: June 6, 2025

500

Area of Science:

  • Neuroscience
  • Computational Chemistry
  • Bioinformatics

Background:

  • Growing interest in G9a's role in neurological processes necessitates efficient research tools.
  • Existing methods for identifying G9a inhibitors can be time-consuming and costly.
  • Machine learning offers a promising avenue for accelerating the discovery and development of G9a-related therapeutics.

Purpose of the Study:

  • To develop three distinct machine learning models for predicting G9a inhibitor properties.
  • To provide researchers with time-efficient and cost-effective computational tools for G9a research.
  • To leverage PubChem data and scikit-learn algorithms for enhanced predictive capabilities.

Main Methods:

  • Development of three machine learning models using Python and the scikit-learn library.
  • Model 1: Gradient Boosting Regressor for predicting G9a inhibitor efficacy.
  • Model 2: Extreme Gradient Boosting Classifier for predicting G9a inhibition based on PubChem identifiers (CID_SID).
  • Model 3: Random Forest Classifier for predicting G9a inhibition using IUPAC names.

Main Results:

  • The Gradient Boosting Regressor achieved a mean relative error of 17.81% for efficacy prediction.
  • The Extreme Gradient Boosting Classifier demonstrated 79.7% accuracy, 83.2% precision, and 78.4% ROC for predicting G9a inhibition from PubChem IDs, with a mean accuracy of 82.75% across seven studies.
  • The Random Forest Classifier achieved 68.2% accuracy using IUPAC names, identifying key molecular fragments like 'iodo' and 'phenylcarbamate' associated with G9a activity.

Conclusions:

  • Machine learning models provide effective and efficient tools for G9a inhibitor research in neuroscience.
  • The developed models demonstrate the potential of computational approaches in accelerating drug discovery.
  • The study highlights the utility of PubChem data and various ML algorithms for predicting compound efficacy and activity.